{"text": "The net health benefit accept- ability curve shows the proportion of trials that attained cost - effectiveness for a given strategy for willingness - to- pay thresholds up to $ 200,000/QALY ( Figure 4 ) .", "label": "", "metadata": {}, "score": "37.258205"}
{"text": "In the probabilistic sensitivity analysis , MRI screening produced a net health benefit of -0.202 QALYs ( 95 % central range : -0.767 QALYs to +0.439 QALYs ) compared to mammography at a willingness - to - pay threshold of $ 50,000/QALY .", "label": "", "metadata": {}, "score": "39.252056"}
{"text": "In the probabilistic sensitivity analysis , MRI screening produced a net health benefit of -0.202 QALYs ( 95 % central range : -0.767 QALYs to +0.439 QALYs ) compared to mammography at a willingness - to - pay threshold of $ 50,000/QALY .", "label": "", "metadata": {}, "score": "39.252056"}
{"text": "After incorporating parameter uncertainty , MRI screening is expected to be a cost - effective option 86 % of the time at a willingness - to - pay of $ 100,000/QALY , and 53 % of the time at a willingness - to - pay of $ 50,000/QALY .", "label": "", "metadata": {}, "score": "40.917206"}
{"text": "Additional File 2 provides the results for univar- iate analyses for all model parameters .In the probabilistic sensitivity analysis , MRI screening produced a net health benefit of -0.202 QALYs ( 95 % cen- tral range : -0.767 QALYs to +0.439 QALYs ) at a willing- ness - to - pay threshold of $ 50,000/QALY .", "label": "", "metadata": {}, "score": "41.122383"}
{"text": "In this model , MRI screening does not approach cost - effectiveness even if a threshold of $ 120,000/QALY is used .Page 6 .", "label": "", "metadata": {}, "score": "41.231903"}
{"text": "Despite high costs and low utilization , the use of r - tPA is \" cost - effective \" at the population level over a 30 year time horizon [ 3 ] .", "label": "", "metadata": {}, "score": "41.253716"}
{"text": "Discussion .With the traditional ICER , we concluded that approximately $ 1000 was the incremental in cost for achieving one additional increase in utilization of health services in the intervention area .", "label": "", "metadata": {}, "score": "42.242542"}
{"text": "Net health benefit acceptability curves Figure 4 Net health benefit acceptability curves .This graph shows the proportion of trials that attained cost - effective- ness for a given strategy for willingness - to - pay thresholds up to $ 200,000/QALY .", "label": "", "metadata": {}, "score": "44.765926"}
{"text": "The incremental cost varies significantly by covariates .The probability of the CBHI achieving a 1 % increase in utilization of health services , when the ceiling ratio is $ 1,000 , is barely 30 % for households in Nouna villages compared to 90 % for households in Nouna town .", "label": "", "metadata": {}, "score": "44.893456"}
{"text": "found that drug costs only accounted for between 1 . 5 - 6 % of the total lifetime medical costs in their model .We found that the cost of rFVIIa would need to be increased substantially before the treatment strategy exceeds the traditional threshold societal willingness to pay of $ 50,000/QALY .", "label": "", "metadata": {}, "score": "45.108856"}
{"text": "This historical threshold is based on the cost of providing care to patients with end - stage renal disease in the 1970s , which now exceeds $ 120,000/QALY .", "label": "", "metadata": {}, "score": "46.845528"}
{"text": "This estimate provides no clue for what to do , how to do it or where to do it if one is concerned with equity issues in universal health coverage .", "label": "", "metadata": {}, "score": "47.024082"}
{"text": "This value is unknown in most cases but in these circumstances , the net - benefit approach has proven feasible and more insightful in assessing cost - effectiveness of a public health intervention aiming at universal health coverage .", "label": "", "metadata": {}, "score": "47.319496"}
{"text": "Even when substituting these less effective neurological outcomes into the base case model , treatment with rFVIIa costs little for the benefit it produces with a mCER of $ 9,541 per QALY .", "label": "", "metadata": {}, "score": "47.743374"}
{"text": "When using these outcomes and varying the probability of developing ATE , the ATE rate must still exceed 18 % for the cost - effectiveness ratio to exceed $ 50,000/QALY .", "label": "", "metadata": {}, "score": "48.01196"}
{"text": "Using an one - level approach the total EVPI for this decision is CHF 9.5 m per 10000 treated patients at a threshold level of 80'000/QALY .", "label": "", "metadata": {}, "score": "51.116432"}
{"text": "Using an one - level approach the total EVPI for this decision is CHF 9.5 m per 10000 treated patients at a threshold level of 80'000/QALY .", "label": "", "metadata": {}, "score": "51.116432"}
{"text": "This is the case with universal health coverage .Computing the ICER point estimate ( assuming we know the context specific ceiling ratio to rule if a good value for money ) does not provide clues about what policy makers could do , how to do it or where to do it when there are important subgroups .", "label": "", "metadata": {}, "score": "51.17144"}
{"text": "Their results have the advantage of Markov modeling across a longer time span , and took into account long - term disability , expected mortality , and cost multipliers ( with appropriate discounting over time ) .", "label": "", "metadata": {}, "score": "51.512283"}
{"text": "Costs ( and ranges for sensitivity analyses ) are presented in Table 2 .We performed a variety of one - way sensitivity analyses to determine how robust our results were in the face of some uncertain input parameter values .", "label": "", "metadata": {}, "score": "51.745884"}
{"text": "Without discounting , MRI provided 23.6 QALYs at a cost of $ 30,380 compared to 23.4 QALYs for mammography at a cost of $ 7,765 .", "label": "", "metadata": {}, "score": "52.630413"}
{"text": "Similarly , if the coefficient is negative , then the incremental cost for one additional unit of effectiveness is above the Ro and the status quo will be deemed cost - effective .", "label": "", "metadata": {}, "score": "52.788147"}
{"text": "Cost .To simplify the analysis , only incremental direct costs during the index hospitalization were considered .Given the short time frame of the model we did not discount costs .", "label": "", "metadata": {}, "score": "52.997696"}
{"text": "Cost data was obtained from Medicare reimbursement in 2012 US dollars .Cost and quality adjusted life years were discounted at 3 % per year .", "label": "", "metadata": {}, "score": "53.164715"}
{"text": "Cost data was obtained from Medicare reimbursement in 2012 US dollars .Cost and quality adjusted life years were discounted at 3 % per year .", "label": "", "metadata": {}, "score": "53.164715"}
{"text": "Earnshaw et al [ 18 ] included indirect medical costs such as caregiver burden in their model .Inclusion of such costs would only be expected to decrease the marginal cost - effectiveness of treatment with rFVIIa .", "label": "", "metadata": {}, "score": "53.560055"}
{"text": "However , despite wide variations of these probabilities in our sensitivity analyses , the models remained robust .The utilities used were derived from quality - adjusted life - year weights from evaluation of very low birth - weight neonates .", "label": "", "metadata": {}, "score": "53.96752"}
{"text": "Moreover , there are very few situations in which decision makers decide to solely go with one strategy over another .Rather , they are more likely to allocate resources across a range of complementary strategies for maximum health gains and thus the net - benefit framework offers an advantage over the traditional ICER approach in presenting and interpreting results for public health interventions ( Table 1 ) .", "label": "", "metadata": {}, "score": "54.106556"}
{"text": "All costs and benefits were discounted at 5 % per year .The analysis was performed from the payer perspective with results reported in 2006 U.S. dollars .", "label": "", "metadata": {}, "score": "54.54103"}
{"text": "All costs and benefits were discounted at 5 % per year .The analysis was performed from the payer perspective with results reported in 2006 U.S. dollars .", "label": "", "metadata": {}, "score": "54.54103"}
{"text": "Differing provisions from the publisher 's actual policy or licence agreement may be applicable .\" The ICER calculated in this study is higher than previously published cost - effectiveness estimates from the UK , but lower than those from the US [ 20 - 22,24].", "label": "", "metadata": {}, "score": "54.679787"}
{"text": "The costs included in the decision tree were derived from published and unpublished sources as listed in Table 2 .Only direct medical costs were included .", "label": "", "metadata": {}, "score": "55.252544"}
{"text": "DISCUSSION .The analysis shows the use of 17\u03b1 - hydroxyprogesterone caproate to be most cost - effective for the prevention of preterm delivery in women with prior delivery at less than 32 weeks or between 32 weeks and 37 weeks using the commonly accepted threshold of $ 50,000 dollars per quality - adjusted life - year gained .", "label": "", "metadata": {}, "score": "55.36138"}
{"text": "Two - way sensitivity analysis of two factors : gargling cost and utility of moderate URTI .Lines indicate the incremental cost effectiveness ratio ( $ /QALY ) for gargling .", "label": "", "metadata": {}, "score": "55.399773"}
{"text": "We also performed sensitivity analyses on the cost of rFVIIa .The base case cost per dose of rFVIIa is $ 6,408 .rFVIIa remains the dominant strategy unless the cost per dose exceeds $ 7,500 .", "label": "", "metadata": {}, "score": "55.95902"}
{"text": "In any case , this type of information is very useful for appraising the likelihood of covariates to affect the cost - effectiveness of the intervention .", "label": "", "metadata": {}, "score": "56.006126"}
{"text": "Thus , it has the potential even for observational studies with patient - level effect and cost data , for the better presentation and interpretation of cost - effectiveness results and better evidence based decision making .", "label": "", "metadata": {}, "score": "56.489216"}
{"text": "The costs of radiation exposure due to annual mammography starting at an earlier age were not incorporated , nor were the costs of possible anxiety and stress from unnecessary biopsies stemming from false positive MRI screening .", "label": "", "metadata": {}, "score": "56.72093"}
{"text": "Variations in costs were based on estimated minimums and maximums from Medicare reimbursement data for hospital , physi- cian , and laboratory services according to the methodol- ogy described in recently published work [ 11].", "label": "", "metadata": {}, "score": "56.813095"}
{"text": "The aim of this study was to assess the feasibility and relative advantages of the net - benefit framework in assessing the cost - effectiveness of an intervention towards universal health coverage compared to the traditional ICER approach .", "label": "", "metadata": {}, "score": "56.857925"}
{"text": "These utilities were applied to each health outcome in the model .As seen in the prob- abilities , ranges for sensitivity analyses were obtained by constructing 95 % confidence intervals for proportions based on published work .", "label": "", "metadata": {}, "score": "56.869186"}
{"text": "As can be seen on Figure 2 if the decision makers in Nouna are only prepared to pay a ceiling ratio less than 400,000 XOF ( $ 920 ) the probability that the Nouna CBHI scheme is preferred or deemed cost effective is small less than 30 % .", "label": "", "metadata": {}, "score": "56.971275"}
{"text": "This study suggests gargling as a cost - effective preventive strategy for URTI that is acceptable from perspectives of both the third - party payer and society .", "label": "", "metadata": {}, "score": "57.135433"}
{"text": "Five thousand bootstrap samplings were used for the incremental cost and effectiveness of the gargling group compared to the control group .Acceptability curve .The curve indicates the probability of gargling being preferable to the control for potential maximum amounts that a decision - maker is willing to pay for an additional increase in QALY .", "label": "", "metadata": {}, "score": "57.289375"}
{"text": "These costs were varied widely ( see Table 2 ) in our sensitivity analysis .We included the nursing charge for only one visit as is the current practice in our unit .", "label": "", "metadata": {}, "score": "57.520058"}
{"text": "10.1002/hec.771 PubMed View Article .Dong H , Kouyate B , Cairns J , Sauerborn R : Differential willingness of household heads to pay community - based health insurance premia for themselves and other household members .", "label": "", "metadata": {}, "score": "57.563957"}
{"text": "We computed for each observation ( household ) in the household survey an individual net - benefit statistic .The interpretation is straightforward and when this difference is greater than zero , it means that the incremental cost for one additional unit of effectiveness ( in this case utilization of health services ) is below the Ro ( the maximum the provider is willing to pay ) .", "label": "", "metadata": {}, "score": "57.7822"}
{"text": "At a willingness to pay threshold of $ 60,000 , surgery became the most cost - effective treatment option .Pelvic floor physical therapy and pelvic floor physical therapy with electrical stimulation were dominated at any willingness to pay threshold .", "label": "", "metadata": {}, "score": "57.983646"}
{"text": "At a willingness to pay threshold of $ 60,000 , surgery became the most cost - effective treatment option .Pelvic floor physical therapy and pelvic floor physical therapy with electrical stimulation were dominated at any willingness to pay threshold .", "label": "", "metadata": {}, "score": "57.983646"}
{"text": "As with sensitivity analysis , the range of variation is subjective , but ranges for many time and cost elements of a project estimate should be skewed toward overrun , due to the natural optimism or omission of the estimator .", "label": "", "metadata": {}, "score": "58.355476"}
{"text": "The findings of this manuscript were similar to ours in that rFVIIa was highly cost - effective .This analysis examined the full range of doses tested in the Phase II study , and while all doses were cost - effective the 80 ug dose was both more effective and less costly .", "label": "", "metadata": {}, "score": "58.622852"}
{"text": "The p - values are 2-sided p - values ; however only one - sided probability is needed to test whether the incremental net - benefit is positive ( Nouna CBHI is preferred ) or negative ( the status quo is preferred ) .", "label": "", "metadata": {}, "score": "58.652252"}
{"text": "For example , when examining the net - benefit regression results ( Table 7 ) it can be noted that only a small fraction ( 3.4 % ) of the variability in cost - effectiveness can be explained by covariates used in the analysis .", "label": "", "metadata": {}, "score": "58.974396"}
{"text": "This important result is more informative than the stratified analysis of the ICER and would not have been possible without a joint probability distribution of the intervention effects and covariates , hence the importance of the net - benefit approach in identifying the effects of important covariates on the cost - effectiveness results .", "label": "", "metadata": {}, "score": "59.005527"}
{"text": "Also , the probability that the Nouna CBHI scheme is cost - effective is higher at any ceiling ratio lower than or equals to 800,000 XOF ( $ 1850 ) when the net - benefits are adjusted to place of residence ( Nouna town versus Nouna villages ) .", "label": "", "metadata": {}, "score": "59.045784"}
{"text": "The screening algorithms for women at increased risk are based on the five aforementioned categories .For women under 25 years of age with a strong family history or genetic predisposition , the recommendation is for annual clinical breast examinations and regular breast self - exam- ination starting at age 18 years [ 5 - 7].", "label": "", "metadata": {}, "score": "59.169655"}
{"text": "Uncertainty and risk are reflected by defining a likely range of variation for each component of the original base case estimate .In practice such an analysis is only done for those variables which have a high impact on cost , time or economic return , and to which the project is most sensitive .", "label": "", "metadata": {}, "score": "59.337353"}
{"text": "By varying the ceiling ratio , the varying probability that the intervention is cost - effective can be identified .The CEAC shows the probability of the intervention being cost - effective for all potential values of the ceiling ratio .", "label": "", "metadata": {}, "score": "59.403336"}
{"text": "Our findings thus challenge the currently fashionable assumption that community based health insurance schemes are a very promising way to extend access to health care in low and middle income countries .", "label": "", "metadata": {}, "score": "59.49044"}
{"text": "No considerations of quality - adjusted life - years were included .Other authors have focused on the economic consequences of very low birth weight infants , a complication of preterm birth .", "label": "", "metadata": {}, "score": "59.53531"}
{"text": "Data from published studies provided probabilities for the model including sensitivity and specificity of each screening strategy .Costs were based on Medicare reimbursement rates for hospital and physician services while medication costs were obtained from the Federal Supply Scale .", "label": "", "metadata": {}, "score": "59.566193"}
{"text": "Data from published studies provided probabilities for the model including sensitivity and specificity of each screening strategy .Costs were based on Medicare reimbursement rates for hospital and physician services while medication costs were obtained from the Federal Supply Scale .", "label": "", "metadata": {}, "score": "59.566193"}
{"text": "Costs of care and ranges explored in sensitivity analyses are shown in Table 2 ( Additional File 1-Current Procedural Terminology codes ) .Utilities Model utilities were measured according to quality adjusted life years ( QALY ) using values between 0 ( death ) and 1 ( perfect ) based on published literature .", "label": "", "metadata": {}, "score": "59.696472"}
{"text": "At the same threshold level treating 10'000 patients with risedronate provides an incremental net monetary benefit of CHF -7'614'108 ( 95 % confidence interval CHF -40'660'215 to CHF 30'282'167 ) .", "label": "", "metadata": {}, "score": "59.759003"}
{"text": "At the same threshold level treating 10'000 patients with risedronate provides an incremental net monetary benefit of CHF -7'614'108 ( 95 % confidence interval CHF -40'660'215 to CHF 30'282'167 ) .", "label": "", "metadata": {}, "score": "59.759003"}
{"text": "We calculated cost - effectiveness as cost per quality - adjusted life - year gained ( QALY ) , and conducted one - way and probabilistic sensitivity analysis .", "label": "", "metadata": {}, "score": "59.765392"}
{"text": "At this point the Nouna CBHI scheme appears to be more costly and more effective .The ICER estimates vary significantly by covariates .For example , the incremental cost for one extra institutional delivery within Nouna villages was 530,600 XOF ( approximately $ 1250 ) compared to 301,700 XOF ( approximately $ 700 ) in Nouna town .", "label": "", "metadata": {}, "score": "59.887226"}
{"text": "Assumptions .Time Horizon of Analysis - We used a time frame for the analysis of one year .Data from the Phase II trial was used for 90 day outcomes , including incremental direct costs of care for use of rFVIIa and complications of ATE .", "label": "", "metadata": {}, "score": "59.993095"}
{"text": "17 These were converted to quality - adjusted life years by using average life expectancy values for the United States , discounted at a 3 % rate .", "label": "", "metadata": {}, "score": "60.009674"}
{"text": "As indicated in the background section , cost effectiveness analysis traditionally relies on use of an incremental cost effectiveness ratio ( ICER ) to indicate , among a set of alternative strategies , which is the most cost effective .", "label": "", "metadata": {}, "score": "60.177834"}
{"text": "Page 2 .This model calcu- lates risk based on current age , age at menarche , age at first live birth , nulliparity , previous breast biopsies , atypical hyperplasia , and race , though it has not been conclusively validated in non - Caucasian women [ 2].", "label": "", "metadata": {}, "score": "60.31069"}
{"text": "Each of these estimates carries inherent uncertainty , as does using a hypothetical cohort .Possible selection bias associated with utilizing the Claus tables may affect our base case effectiveness and resource use estimates by either over or underestimating our base case model parameters .", "label": "", "metadata": {}, "score": "60.338104"}
{"text": "The CEAC can also be interpreted as showing for a given threshold value the probability that the intervention is cost - effective .Although possible in theory , a probability that the intervention is 100 % cost - effective will never be observed in reality .", "label": "", "metadata": {}, "score": "60.64692"}
{"text": "The CEAC can also be interpreted as showing for a given threshold value the probability that the intervention is cost - effective .Although possible in theory , a probability that the intervention is 100 % cost - effective will never be observed in reality .", "label": "", "metadata": {}, "score": "60.64692"}
{"text": "The incremental cost - effectiveness ratios is the additional cost of moving from a policy of no treatment to using 17\u03b1 - hydroxyprogesterone caproate .Due to the considerable uncertainty regarding several of our baseline assumptions , we performed one - way and multi - way sensitivity analyses ( effect of varying the baseline estimates on the results ) commensurate with the degree of uncertainty for each point estimate .", "label": "", "metadata": {}, "score": "60.694656"}
{"text": "These results are presented in Figure 2 , along with sensitivity analyses in which the lowest and highest costs of neurologic outcomes were varied from the base case costs .", "label": "", "metadata": {}, "score": "60.769764"}
{"text": "Since the in - service life of the resulting product is typically much longer than the period required to plan and produce that product , any quality shortcomings and their effects may surface over a prolonged period of time .", "label": "", "metadata": {}, "score": "61.344055"}
{"text": "This form of risk analysis is usually applied to cost and time considerations , both in choosing between different early investment decisions , and later in considering major changes with uncertain outcomes during project implementation .", "label": "", "metadata": {}, "score": "61.408554"}
{"text": "The full results are not presented here as the goal is primarily to demonstrate the applicability of the net - benefit framework to observational public health studies rather than the robustness of the results or any model .", "label": "", "metadata": {}, "score": "61.587006"}
{"text": "The 95 % confidence interval ( 95%CI ) and probability of gargling being cost - effective were estimated by bootstrapping .RESULTS : .After 60 days , QALD was increased by 0.43 and costs were $ 37.1 higher in the gargling group than in the control group .", "label": "", "metadata": {}, "score": "61.715027"}
{"text": "Results : Analysis of the model showed that incontinence pessary was the most cost - effective treatment option with a cost of $ 11,411 for 18.9 quality adjusted life years .", "label": "", "metadata": {}, "score": "61.78108"}
{"text": "Results : Analysis of the model showed that incontinence pessary was the most cost - effective treatment option with a cost of $ 11,411 for 18.9 quality adjusted life years .", "label": "", "metadata": {}, "score": "61.78108"}
{"text": "In all situations , the patients continue annual screen- ing until death .Probabilities of living differ for the three scenarios and , like all other model probabilities including sensitivity and specificity of each screening strategy , are based on published literature .", "label": "", "metadata": {}, "score": "61.87571"}
{"text": "Van Hout VA , Al MJ , Gordon GS , Rutten FF : Costs , effects and C / E ratios alongside a clinical trial .", "label": "", "metadata": {}, "score": "62.131012"}
{"text": "Probabilities , success rates and utilities for health outcomes were obtained from the literature or , when unavailable , by expert opinion .A cost utility analysis was performed using US recommendations from a societal perspective .", "label": "", "metadata": {}, "score": "62.481205"}
{"text": "Probabilities , success rates and utilities for health outcomes were obtained from the literature or , when unavailable , by expert opinion .A cost utility analysis was performed using US recommendations from a societal perspective .", "label": "", "metadata": {}, "score": "62.481205"}
{"text": "However , both univariate and probabilistic sensitivity analyses were performed to address uncertainty in parameter estimates by exploring variability in each probability , cost , and outcome esti- mate .", "label": "", "metadata": {}, "score": "62.538963"}
{"text": "This is due to the uncertainty that was explicitly taken into account using probability distributions instead of point estimates for the model input parameters .With perfect information ( no parameter uncertainty ) there would not be the possibility of making the \" wrong \" decision .", "label": "", "metadata": {}, "score": "62.84214"}
{"text": "This is due to the uncertainty that was explicitly taken into account using probability distributions instead of point estimates for the model input parameters .With perfect information ( no parameter uncertainty ) there would not be the possibility of making the \" wrong \" decision .", "label": "", "metadata": {}, "score": "62.84214"}
{"text": "The most important advantage in our view is the possible information on the marginal cost - effectiveness of important covariates particularly when decision makers are concerned with important determinants or equity as is often the case in public health interventions .", "label": "", "metadata": {}, "score": "63.044548"}
{"text": "The values of individual model parameters above or below which MRI became cost - effective were recorded as thresholds .In addition to the univariate sensitivity analyses , a probabil- istic sensitivity analysis was performed with 10,000 Monte Carlo simulations to assess the robustness of the findings in the base case .", "label": "", "metadata": {}, "score": "63.20578"}
{"text": "The sensitivity analysis shown in Figure 5 allows us to consider the impact of future trial results that fall somewhere along this spectrum .The discrepancy seen between the early clinical trials and the FAST trial was discussed in the FAST results presentation .", "label": "", "metadata": {}, "score": "63.374752"}
{"text": "Probability analysis overcomes the limitations of sensitivity analysis by specifying a probability distribution for each variable , and then considering situations where any or all of these variables can be changed at the same time .", "label": "", "metadata": {}, "score": "63.39169"}
{"text": "Probability ranges were obtained by con- structing 95 % confidence intervals for proportions derived from the literature using normal approximations to the binomial distribution .The probabilities used in the model and ranges explored in univariate sensitivity analy- ses are shown in Table 1[11,17 - 22].", "label": "", "metadata": {}, "score": "63.57428"}
{"text": "Page 4 .Page 5 .Results The MRI strategy provided 14.1 QALYs at a discounted cost of $ 18,167 while mammography provided 14.0 QALYs at a discounted cost of $ 4,760 over 25 years of screening ( Table 4 ) .", "label": "", "metadata": {}, "score": "63.632347"}
{"text": "In addition , the prob- abilities and utilities used in both the above studies are different from those used in our model .Our study has some limitations that must be addressed .", "label": "", "metadata": {}, "score": "63.698593"}
{"text": "A feature of project work is that a number of options are typically available in the course of reaching the final results .An advantage of decision tree analysis is that it forces consideration of the probability of each outcome .", "label": "", "metadata": {}, "score": "63.717453"}
{"text": "The further breakdown into subgroups when calculating the EVSI allows us to identify which groups of parameters have the highest impact on total parameter uncertainty .", "label": "", "metadata": {}, "score": "63.94855"}
{"text": "The further breakdown into subgroups when calculating the EVSI allows us to identify which groups of parameters have the highest impact on total parameter uncertainty .", "label": "", "metadata": {}, "score": "63.94855"}
{"text": "The bias introduced into our analysis by a short time horizon should only make rFVIIa appear more costly and less effective .Extending the time horizon of the analysis would only increase the marginal effectiveness and perhaps decrease the marginal cost of rFVIIa .", "label": "", "metadata": {}, "score": "64.03639"}
{"text": "Its application requires the availability of person - level or household - level effect and cost data collection , which in turn will require change to current well established tools and methods of national or sub national household surveys .", "label": "", "metadata": {}, "score": "64.077995"}
{"text": "This is where the net - benefit framework could potentially be very useful in assessing the effect of significant determinants on the marginal cost - effectiveness of a universal health coverage intervention such as the Nouna community based health insurance .", "label": "", "metadata": {}, "score": "64.310135"}
{"text": "Although this resembles many acceptable forms of medical intervention , including URTI preventive measures such as influenza vaccination , the broad confidence interval indicates uncertainty surrounding our results .", "label": "", "metadata": {}, "score": "64.37187"}
{"text": "Conclusions .There are some challenges in interpreting the traditional ICER results .Regardless of the accuracy of the costing methodology , there remain issues about the level of certainty of the computed estimate .", "label": "", "metadata": {}, "score": "64.41058"}
{"text": "The basic concept is to derive a consensus using a panel of experts to arrive at a convergent solution to a specific problem .This is particularly useful in arriving at probability assessments relating to future events where the risk impacts are large and critical .", "label": "", "metadata": {}, "score": "64.71675"}
{"text": "One modelling study found that screening decreased the mortality from breast cancer by 7 % - 23 % , and that when combined with adju- vant therapy , the rate declined by 25 % - 38 % [ 9 - 12].", "label": "", "metadata": {}, "score": "64.91747"}
{"text": "Keywords .Cost - effectiveness analysis Net - benefit framework Universal health coverage .Electronic supplementary material .The online version of this article ( doi : 10 .", "label": "", "metadata": {}, "score": "65.26226"}
{"text": "New interventions in clinical medicine are likely to be more effective and more costly because breakthroughs in medical procedures and new technologies are typically more expensive than existing practices .", "label": "", "metadata": {}, "score": "65.294556"}
{"text": "The findings are not shocking given the cheap cost of 17\u03b1 - hydroxyprogesterone caproate , relative to the cost and consequences of preterm delivery .The results of the cost per number of preterm delivery less than 32 weeks or 37 weeks or the number of neonatal complications prevented , are difficult to interpret because there is no a priori established willingness - to - pay threshold for the prevention of preterm delivery or the associated neonatal complications .", "label": "", "metadata": {}, "score": "65.41609"}
{"text": "Both low and high incremental cost - effectiveness ratios ( ICERs ) were recorded in univariate analyses and parameters were var- ied across their distributions in probabilistic sensitivity analyses .", "label": "", "metadata": {}, "score": "65.54481"}
{"text": "CONCLUSION :Within our baseline assumptions , 17\u03b1 - hydroxyprogesterone caproate was associated with cost - savings when used for the prevention of preterm deliveries in women with prior preterm deliveries .", "label": "", "metadata": {}, "score": "65.58624"}
{"text": "Quality of life estimates also have a substantial impact on total parameter uncertainty , the other subgroups such as costs and transition probabilities only have a relatively low impact on total EVPI .", "label": "", "metadata": {}, "score": "65.68761"}
{"text": "Quality of life estimates also have a substantial impact on total parameter uncertainty , the other subgroups such as costs and transition probabilities only have a relatively low impact on total EVPI .", "label": "", "metadata": {}, "score": "65.68761"}
{"text": "Probabilities and Rates .The rate of ATE among all patients treated with rFVIIa in the Phase II trial was 2 % [ 9 ] .", "label": "", "metadata": {}, "score": "65.69212"}
{"text": "Parameter uncertainty in quality of life estimates was represented by beta distributions .PSA was performed with 5000 Monte Carlo simulations .Results .The incremental cost - effectiveness ratio for risedronate treatment when compared to no treatment is CHF 110'982 per QALY .", "label": "", "metadata": {}, "score": "65.705696"}
{"text": "Parameter uncertainty in quality of life estimates was represented by beta distributions .PSA was performed with 5000 Monte Carlo simulations .Results .The incremental cost - effectiveness ratio for risedronate treatment when compared to no treatment is CHF 110'982 per QALY .", "label": "", "metadata": {}, "score": "65.705696"}
{"text": "Each subgroup was compared with a \" no treatment \" group .Costs included those for 17\u03b1 - hydroxyprogesterone caproate , hospital admissions , and complications from preterm deliveries .", "label": "", "metadata": {}, "score": "65.725845"}
{"text": "For best results , the panel members should not know each other identity and the process should be conducted with each at separate locations .The responses , together with opinions and justifications , are evaluated and statistical feedback is furnished to each panel member in the next iteration .", "label": "", "metadata": {}, "score": "65.87942"}
{"text": "The probability of neonatal death and morbidity were obtained from a study of the use of antenatal steroids to prevent respiratory distress syndrome and related morbidity and mortality in premature infants .", "label": "", "metadata": {}, "score": "65.97183"}
{"text": "If one believes the results of the phase III trial are correct ( efficacy in preventing major neurological sequelae and in preventing death equal zero ) , then usual care is best .", "label": "", "metadata": {}, "score": "65.9978"}
{"text": "A probabilistic model was developed to combine within - trial and beyond - trial impacts of treatment to estimate the lifetime costs and benefits of two secondary prevention strategies : Intervention - tailored practice and patient care plans ; and Control - standardized usual care .", "label": "", "metadata": {}, "score": "66.32803"}
{"text": "Our data suggest that doing so is reasonable up to a point , as treatment with rFVIIa remains ' cost - effective ' at higher levels of ATE .", "label": "", "metadata": {}, "score": "66.475395"}
{"text": "And the relative importance of each variable examined is readily apparent .Some weaknesses are that variables are treated individually , limiting the extent to which combinations of variables can be assessed , and a sensitivity diagram gives no indication of anticipated probability of occurrence .", "label": "", "metadata": {}, "score": "66.60881"}
{"text": "All authors read and approved the final manuscript .References 1 .Jemal A , Siegel R , Ward E , Hao Y , Xu J , Murray T , Thun MJ : Cancer Statistics , 2008 .", "label": "", "metadata": {}, "score": "66.651634"}
{"text": "Under the baseline assumptions , the model favors the use of 17\u03b1 - hydroxyprogesterone caproate in women with a history of preterm delivery less than 32 weeks and between 32 weeks and 37 weeks as the most cost - effective compared with the other strategies .", "label": "", "metadata": {}, "score": "66.71534"}
{"text": "For negative incremental net - benefits the probabilities that Nouna CBHI is preferred equals the one sided p - values , and for positive incremental net - benefits , the probabilities that the Nouna CBHI is preferred equals 1 minus the one sided p - values ( Hoch JS et al , 2006 ) .", "label": "", "metadata": {}, "score": "66.74089"}
{"text": "10.1016/S0167 - 6296(98)00039 - 3 View Article .Briggs A , Fenn P : Confidence intervals or surfaces ?Uncertainty of the cost - effectiveness plane .", "label": "", "metadata": {}, "score": "66.85599"}
{"text": "Our main findings are that physician quality , better education , having a partner , younger age and better health are associated with higher rates of receipt .", "label": "", "metadata": {}, "score": "66.90335"}
{"text": "Health Econ 2002 , 11 : 415 - 430 .10.1002/hec.678 PubMed View Article .Hoch JS , Rockx MA , Krahn AD : Using net - benefit regression framework to construct cost - effectiveness acceptability curves : an example using data from a trial of external loop recorders versus Holter monitoring for ambulatory monitoring of \" community acquired \" syncope .", "label": "", "metadata": {}, "score": "66.97713"}
{"text": "Lothgren M , Zethraeus N : Definitions , interpretation and calculation of cost effectiveness acceptability curves .Health Econ 2000 , 9 : 623 - 630 .", "label": "", "metadata": {}, "score": "67.07089"}
{"text": "This is the main potential of the net - benefit framework when applying to public health interventions such as universal health coverage .Lastly , while the main concern of this paper is with methodological challenges , the high values of the ceiling ratios that we found for the CHBI scheme to be cost - effective are of interest .", "label": "", "metadata": {}, "score": "67.07587"}
{"text": "However , the cost - effectiveness of gargling from a societal perspective should be considered .In this study , economic evaluation alongside a randomized controlled trial was performed to evaluate the cost - effectiveness of gargling for preventing URTI from a societal perspective .", "label": "", "metadata": {}, "score": "67.1165"}
{"text": "10.1093/heapol / czh014 PubMed View Article .De Allegri M , Sauerborn R : Community based health insurance in developing countries .BMJ 2007 , 334 ( 7607):1282 - 1283 .", "label": "", "metadata": {}, "score": "67.15921"}
{"text": "Each trial point provides a comparison of the incremental costs and benefits of MRI screening to mam- mogaphy .For each comparison , parameters for both screening strategies were simultaneously and randomly sampled from the probability , cost , and outcome distribu- tions to account for uncertainty in the base case parameter estimates .", "label": "", "metadata": {}, "score": "67.212524"}
{"text": "Br J Cancer 2004 , 91:1893 - 1901 .Levin HM , McEwan PJ : Cost - Effectiveness Analysis : Methods and Applica- tions 2nd edition .", "label": "", "metadata": {}, "score": "67.27459"}
{"text": "Neither costs nor outcomes were dis- counted since costs and benefits all occurred within the year that resources were utilized and each strategy required the recurring costs of screening .", "label": "", "metadata": {}, "score": "67.38229"}
{"text": "Figure 1 shows the abbreviated model for the use of 17\u03b1 - hydroxyprogesterone caproate in women with prior delivery less than 32 weeks .The full models can be obtained from the authors if desired .", "label": "", "metadata": {}, "score": "67.42566"}
{"text": "Since we hypothesized that rFVIIa would result in improved clinical outcomes and a mCER that would be acceptable from a societal perspective , any bias introduced into the analysis by not incorporating a longer analytic time horizon would be against the active intervention with rFVIIa .", "label": "", "metadata": {}, "score": "67.57419"}
{"text": "Data were collected from April to December 2007 from Nouna 's longitudinal Demographic Surveillance System on utilization of health services , membership of the CBHI , covariates , and CBHI costs .", "label": "", "metadata": {}, "score": "67.58057"}
{"text": "It follows that quality management can have the most impact on the long - term actual or perceived success of the project .Risk Perceptions .", "label": "", "metadata": {}, "score": "67.64395"}
{"text": "Costs .Information about the cost of rFVIIa was obtained from the University of Cincinnati pharmacy .For an 80 mcg / kg dose in an 80 kg patient , the cost of rFVIIa is $ 6,408 ( personal communication , K. Sangha , PharmD , 2/16/2006 ) .", "label": "", "metadata": {}, "score": "67.67583"}
{"text": "a. Assess the range of the variables being considered and determine the probability distribution most suited to each .b. For each variable within its specific range , select a value randomly chosen , taking account of the probability distribution for the occurrence of the variable .", "label": "", "metadata": {}, "score": "67.75432"}
{"text": "We considered direct medical costs only and did not include indirect costs such as costs from work time loss or loss of future earnings .This is due to lack of reliable data on such costs .", "label": "", "metadata": {}, "score": "67.7726"}
{"text": "Should future studies demonstrate these efficacies to be greater than those falling along this threshold line , rFVIIa would be \" cost - effective . \" The results were insensitive to changes in a number of other parameters including the probability of dying after an ATE and the utility for neurological outcomes in survivors of ischemic stroke or myocardial infarction ( due to ATE ) .", "label": "", "metadata": {}, "score": "67.874435"}
{"text": "Data from the Phase II trial ( testing 3 doses ) showed a dose effect , in that the 80 ug / kg dose was more effective than the 40 ug / kg dose .", "label": "", "metadata": {}, "score": "67.89703"}
{"text": "The Quality Risk .This risk can best be expressed by the question : \" What if the project fails to perform as expected during its operational life ?", "label": "", "metadata": {}, "score": "67.90294"}
{"text": "Overall , lower ceiling ratios are needed to achieve a given probabilities that the Nouna CBHI is cost - effective in Nouna town versus Nouna villages .", "label": "", "metadata": {}, "score": "67.9205"}
{"text": "Among participants in the gargling trial , 122 water - gargling and 130 control subjects were involved in the economic analysis .Sixty - day cumulative follow - up costs and effectiveness measured by quality - adjusted life days ( QALD ) were compared between groups on an intention - to - treat basis .", "label": "", "metadata": {}, "score": "68.03441"}
{"text": "Thus , we compared the neurological outcomes from the placebo arm ( usual care ; no treatment ) of the Phase II trial to the results of treatment with rFVIIa at 80 ug / kg .", "label": "", "metadata": {}, "score": "68.30168"}
{"text": "Based upon the published results of the phase II trial , the treatment of eligible ICH patients with rFVIIa would be promising from both a clinical and economic point of view , resulting in better outcomes at a lower cost than conventional management .", "label": "", "metadata": {}, "score": "68.306915"}
{"text": "Relative advantages of net - benefit framework and incremental cost - effectiveness ratio for presenting and interpreting results of cost - effectiveness analysis .Graphical presentation ; illustration of alternative scenarios with different ceiling ratios .", "label": "", "metadata": {}, "score": "68.34121"}
{"text": "Once established , risk perceptions are extremely hard to change .New information may be absorbed by the intellect , but it is not readily absorbed at an emotional level .", "label": "", "metadata": {}, "score": "68.35471"}
{"text": "Start Date .End Date .Description .Objective : There are many possible treatment options for stress urinary incontinence .We sought to investigate the cost - utility of non - surgical versus surgical treatments .", "label": "", "metadata": {}, "score": "68.393486"}
{"text": "Additionally , a probabilistic sensitivity analysis was performed to assess the robustness of the findings in the base case .The net health benefits of MRI screening rel-", "label": "", "metadata": {}, "score": "68.577866"}
{"text": "When considering preterm delivery less than 32 weeks averted , the cost - effectiveness ratio ( $ 95,402 ) was more favorable in the strategy using 17\u03b1 - hydroxyprogesterone caproate in women with prior delivery less than 32 weeks , compared with the other strategies .", "label": "", "metadata": {}, "score": "68.74428"}
{"text": "This analysis was sensitive to the probability of delivering less than 32 weeks while on 17\u03b1 - hydroxyprogesterone caproate .The critical threshold was 31.5 % , which is close to our baseline probability of preterm delivery less than 32 weeks ( 30 % ) .", "label": "", "metadata": {}, "score": "68.832664"}
{"text": "Utilities for mRS 2 - 3 and 4 - 5 are derived from Post 's systematic review of the literature [ 14 ] .For each outcome state , a base case estimate and a utility range are presented , including a negative utility for mRS of 4 - 5 since some patients consider this outcome to be worse than death ( see Table 1 ) .", "label": "", "metadata": {}, "score": "68.83288"}
{"text": "They take risk every day , both consciously and subconsciously , and they are willing and able to take benefit / risk decisions , as in driving and speeding .", "label": "", "metadata": {}, "score": "68.86316"}
{"text": "18 The cost for NICU stay was prorated according to the expected average duration of admission .All costs were discounted at a rate of 3 % .", "label": "", "metadata": {}, "score": "69.397156"}
{"text": "Probability distributions are fitted to model parameters from input data .For PSA the decision model is then recalculated many times ( e.g. 1000 iterations are performed ) .", "label": "", "metadata": {}, "score": "69.605606"}
{"text": "Probability distributions are fitted to model parameters from input data .For PSA the decision model is then recalculated many times ( e.g. 1000 iterations are performed ) .", "label": "", "metadata": {}, "score": "69.605606"}
{"text": "Is used extensively in formative project planning and can also be used to advantage to identify and postulate risk scenarios for a particular project .It is a simple but effective attempt to help people think creatively in a group setting without feeling inhibited or being criticized by others .", "label": "", "metadata": {}, "score": "69.64614"}
{"text": "Although , based on existing evi- dence , current screening consideration of MRI screening in this high - risk popula- tion [ 11 ] , its use remains controversial .", "label": "", "metadata": {}, "score": "69.810196"}
{"text": "We made several simplifying assumptions about the costs of the various neurologic outcomes .For mRS 0 - 1 ( \" mild impairment \" ) , we assigned outpatient rehabilitation costs only .", "label": "", "metadata": {}, "score": "69.81383"}
{"text": "Methods .A probabilistic Markov model with 7 health states was developed .All transition probabilities , costs , utilities and other model parameters were taken from published studies or official sources .", "label": "", "metadata": {}, "score": "69.83746"}
{"text": "Methods .A probabilistic Markov model with 7 health states was developed .All transition probabilities , costs , utilities and other model parameters were taken from published studies or official sources .", "label": "", "metadata": {}, "score": "69.83746"}
{"text": "Review of the Data .Clinical Outcomes and Utilities .We used previously published utilities for stroke outcomes derived from time - trade off analyses .", "label": "", "metadata": {}, "score": "69.9059"}
{"text": "Other studies evaluating the economic burden of preterm births have been limited to costs of hospitalization in the prenatal and neonatal period .16,23 - 25 For example , Petrou 23 evaluated the economic consequences of preterm birth in the first year of life .", "label": "", "metadata": {}, "score": "69.94666"}
{"text": "The public may greatly underestimate familiar risks ( e.g. driving ) while greatly overestimating unfamiliar risks ( e.g. buying a home near a nuclear facility ) .", "label": "", "metadata": {}, "score": "69.95146"}
{"text": "The alternative intervention will be the status quo ( no enrolment in the CBHI ) .Data collection and analysis .Data were extracted from the longitudinal Nouna demographic and surveillance site on membership of the Nouna CBHI , utilization of health services , the average distance from village to health centre , assets ownership , age and education level of the head of household .", "label": "", "metadata": {}, "score": "69.99634"}
{"text": "J Natl Compr Canc Netw 2006 , 4:480 - 508 .Gail MH , Brinton LA , Byar DP , Corle DK , Green SB , Schairer C , Mul- vihill JJ : Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined Annually .", "label": "", "metadata": {}, "score": "70.00601"}
{"text": "Abstract .OBJECTIVE :To evaluate whether the use of 17\u03b1 - hydroxyprogesterone caproate for the prevention of recurrent preterm deliveries is cost - effective .", "label": "", "metadata": {}, "score": "70.09924"}
{"text": "View Article PubMed .Holloway RG , Witter DM Jr , Lawton KB , Lipscomb J , Samsa G : Inpatient costs of specific cerebrovascular events at five academic medical centers .", "label": "", "metadata": {}, "score": "70.23805"}
{"text": "The coefficients were obtained from an Ordinary Least Squares ( OLS ) regression as explained above and correspond to the increment net - benefit .Table 4 presents the variations of the incremental net benefit of the intervention with different ceiling ratios and the probability of cost - effectiveness of Nouna CBHI with different ceiling ratios .", "label": "", "metadata": {}, "score": "70.3152"}
{"text": "The use of 17\u03b1 - hydroxyprogesterone caproate in women with previous term or no prior delivery was also found to be cost - effective using the same threshold of $ 50,000 dollars per quality - adjusted life - year gained .", "label": "", "metadata": {}, "score": "70.42857"}
{"text": "In this recent publication , arterial thromboembolic events that could result from treatment with rFVIIa were not considered .It is important to consider such adverse events , as they impact upon costs , mortality , and long - term outcome for survivors .", "label": "", "metadata": {}, "score": "70.46338"}
{"text": "CO;2-O PubMed View Article .Briggs AH , Gray AM : Handling uncertainty when performing economic evaluation of healthcare interventions .Health Technol Assess 1999 , 3 ( 2):1 - 134 .", "label": "", "metadata": {}, "score": "70.54904"}
{"text": "Utility theory endeavors to formalize management 's attitude towards risk , an approach that is appropriate to decision tree analysis for the calculation of expected values , and also for the assessment of results from sensitivity and probability analyses .", "label": "", "metadata": {}, "score": "70.55471"}
{"text": "If these results are reproducible and generalizable , the use of rFVIIa would not be cost - effective as its use would result in added cost with no increase in effectiveness .", "label": "", "metadata": {}, "score": "70.860374"}
{"text": "\" For several reasons , cost considerations are important before a universal policy of 17\u03b1 - hydroxyprogesterone caproate for all women considered at risk for preterm delivery could be adopted .", "label": "", "metadata": {}, "score": "70.863785"}
{"text": "Data provided are for informational purposes only .Although carefully collected , accuracy can not be guaranteed .The impact factor represents a rough estimation of the journal 's impact factor and does not reflect the actual current impact factor .", "label": "", "metadata": {}, "score": "71.1013"}
{"text": "Page 3 .The Markov model considered one cycle to be a full year , accounting for each time a patient underwent screening .In the model , patients are initially screened with either MRI or mammography .", "label": "", "metadata": {}, "score": "71.13085"}
{"text": "In high - risk women , who tend to develop breast cancer at earlier ages , however , mammography screening is less sensitive , largely due to problems detecting cancer in dense breast tissue .", "label": "", "metadata": {}, "score": "71.291794"}
{"text": "Lancet 2002 , 359:909 - 919 .Tabar L , Vitak B , Chen HH , Yen MF , Duffy SW , Smith RA : Beyond randomized controlled trials : organized mammographic Additional file 1 Current procedural terminology codes .", "label": "", "metadata": {}, "score": "71.46356"}
{"text": "First , we varied the direct cost of neurological outcomes to the highest and lowest costs in the proposed range , respectively .Not surprisingly , when costs of poor neurologic outcome are higher than the base case , treatment with rFVIIa dominates conventional therapy .", "label": "", "metadata": {}, "score": "71.559204"}
{"text": "Sensitivity analysis has always played an important role in decision analytic modelling .One - way sensitivity analysis is still the method of choice for the analysis of methodological uncertainty ( e.g. the analysis of different starting parameters in the model ) .", "label": "", "metadata": {}, "score": "71.62012"}
{"text": "Sensitivity analysis has always played an important role in decision analytic modelling .One - way sensitivity analysis is still the method of choice for the analysis of methodological uncertainty ( e.g. the analysis of different starting parameters in the model ) .", "label": "", "metadata": {}, "score": "71.62012"}
{"text": "24].\" MRI is more sensitive than mammography but is more costly and produces more false positive results .The purpose of this study was to calculate the cost - effectiveness of MRI screening for breast cancer in BRCA1/2 mutation carriers in a Canadian setting .", "label": "", "metadata": {}, "score": "71.67654"}
{"text": "Breast MRI provided 14.1 discounted quality - adjusted life - years ( QALYs ) at a discounted cost of $ 18,167 while mammography provided 14.0 QALYs at a cost of $ 4,760 over 25 years of screening .", "label": "", "metadata": {}, "score": "71.70664"}
{"text": "Results : Breast MRI provided 14.1 discounted quality - adjusted life - years ( QALYs ) at a discounted cost of $ 18,167 while mammography provided 14.0 QALYs at a cost of $ 4,760 over 25 years of screening .", "label": "", "metadata": {}, "score": "71.73759"}
{"text": "Abstract .In assessing the cost - effectiveness of an intervention , the interpretation and handling of uncertainties of the traditional summary measure , the Incremental Cost Effectiveness Ratio ( ICER ) , can be problematic .", "label": "", "metadata": {}, "score": "71.74446"}
{"text": "The major limitation of this study was that this trial was conducted in winter , at a time when URTI is prevalent .Care must be taken when applying the results to a season when URTI is not prevalent , since the ICER will increase due to decreases in incidence .", "label": "", "metadata": {}, "score": "71.813446"}
{"text": "Conclusion .In light of our results , and those of Earnshaw and colleagues , we believe that another Phase III trial should be considered .", "label": "", "metadata": {}, "score": "71.918"}
{"text": "Share .Objective : There are many possible treatment options for stress urinary incontinence .We sought to investigate the cost - utility of non - surgical versus surgical treatments .", "label": "", "metadata": {}, "score": "72.1895"}
{"text": "The cost - effectiveness of MRI screening in this model strongly depended on several factors , including the likelihood of survival with node - negative breast cancer , survival with node - positive breast cancer , positive mam- mography reading , and positive MRI reading .", "label": "", "metadata": {}, "score": "72.23439"}
{"text": "We performed an incremental cost - effectiveness analysis from the societal perspective , considering conventional management vs. 80 ug / kg rFVIIa treatment for acute ICH cases meeting Phase II inclusion criteria .", "label": "", "metadata": {}, "score": "72.47847"}
{"text": "Further sensitivity analyses were performed to explore the impact of changes in the cost of rFVIIa , the direct costs of neurological outcomes , the probability of ATE , and outcomes after ATE .", "label": "", "metadata": {}, "score": "72.54404"}
{"text": "Normal distributions were used with base The Markov model Figure 1 The Markov model .This model considers one cycle to be a full year , accounting for each time a patient underwent screening .", "label": "", "metadata": {}, "score": "72.66246"}
{"text": "Sensitivity analysis seeks to place a value on the effect of change of a single variable within a project by analyzing that effect on the project plan .", "label": "", "metadata": {}, "score": "72.7858"}
{"text": "Although the baseline decision should in this case be to not provide risedronate , the upper boundary of the confidence interval would suggest that there is a potential net monetary benefit of risedronate therapy of CHF 30 m per 10000 treated patients .", "label": "", "metadata": {}, "score": "72.79364"}
{"text": "Although the baseline decision should in this case be to not provide risedronate , the upper boundary of the confidence interval would suggest that there is a potential net monetary benefit of risedronate therapy of CHF 30 m per 10000 treated patients .", "label": "", "metadata": {}, "score": "72.79364"}
{"text": "Moore et al10 argue that breast MRI does not appear to be a cost effective screening option for high - risk women .[ Show abstract ] [ Hide abstract ] ABSTRACT : Breast cancer incidence is increasing worldwide .", "label": "", "metadata": {}, "score": "72.938705"}
{"text": "Unfortunately , spontaneous hor- mone - induced enhancement may occur , leading to false positive test results and unnecessary biopsies in women screened by MRI over mammography .", "label": "", "metadata": {}, "score": "72.95491"}
{"text": "We performed our cost - effectiveness analysis from a societal perspective , considering the decision only for those cases of ICH that would have met inclusion criteria in the Phase II trial .", "label": "", "metadata": {}, "score": "73.13266"}
{"text": "Brouwer W , van Hout B , Rutten F : A fair approach to discount- ing future effects : taking a societal perspective .J Health Serv Res Policy 2000 , 5:114 - 118 .", "label": "", "metadata": {}, "score": "73.33766"}
{"text": "BK conceived of the study and performed the data review .Together , BK and ME developed the model parameters , designed the model , analyzed the model results , and generated the figures for the manuscript .", "label": "", "metadata": {}, "score": "73.389275"}
{"text": "Reports of studies from the 1970s and 1980s showed conflicting findings on the efficacy of using progestational agents to prevent preterm births .2 Two recent randomized - controlled trials have rekindled interest in the use of progestational agents for preventing preterm birth .", "label": "", "metadata": {}, "score": "73.40289"}
{"text": "Results of the Phase III study ( r F VIIa in A cute Hemorrhagic S troke T reatment ; FAST trial ) have recently been presented ( Mayer et al , AAN meeting ) .", "label": "", "metadata": {}, "score": "73.52643"}
{"text": "Applying the net - benefit regression approach .Table 3 presents the results of the overall economic evaluation with a range of arbitrary ceiling ratios ( arbitrary but selected around the sample ICER ) .", "label": "", "metadata": {}, "score": "73.61351"}
{"text": "Beyond an efficacy of 18 % , rFVIIa is both less expensive and more effective than usual care .In Figure 5 , we explore both the efficacy of preventing major neurological sequelae ( on the horizontal axis ) and the efficacy in preventing death ( on the vertical axis ) .", "label": "", "metadata": {}, "score": "73.83563"}
{"text": "10.1016/j.jhealeco.2007.07.002 PubMed View Article .Claxton K : The irrelevance of inference : a decision making framework to the stochastic evaluation of health care technologies .", "label": "", "metadata": {}, "score": "73.90389"}
{"text": "Survivors of ATE were arbitrarily assigned a 55 % decrease in the expected utility for the post - ICH mRS ( from the 80 ug / kg group ) due to the further insult of the ATE .", "label": "", "metadata": {}, "score": "73.93796"}
{"text": "Conclusions : Decision makers in both settings must determine whether the level of evidence presented is sufficient to justify the adoption of the SPHERE intervention in clinical practice .", "label": "", "metadata": {}, "score": "74.033424"}
{"text": "Following this visit , the patients self - administer the medication .For hospital admissions secondary to preterm labor we used an average between hospital charges for an average length of stay of 3 days and values from Nicholson et al 15 based on Maryland State discharge data , including costs for a 48-hour course of magnesium sulfate and dexamethasone .", "label": "", "metadata": {}, "score": "74.10402"}
{"text": "View Article PubMed .Lau J , Kassirer JP , Pauker SG : Decision Maker 3 .Improved decision analysis by personal computer .Med Decis Making 1983 , 3 : 39 - 43 .", "label": "", "metadata": {}, "score": "74.117004"}
{"text": "P - values are the level of significance on the Pearson chi - square test between enrolment and covariates .There is no difference by age or sex between members and not members .", "label": "", "metadata": {}, "score": "74.27672"}
{"text": "25 years : data from the Phase II trial was used for 90 day outcomes and rFVIIa complications - arterial thromboembolic events ( ATE ) .", "label": "", "metadata": {}, "score": "74.312836"}
{"text": "Such studies should address the utility of outcomes from preterm births both from the parental perspective as well as the perspective of providers .In conclusion , despite the limitations of this analysis , the use of 17\u03b1 - hydroxyprogesterone caproate was associated with cost - savings with respect to prevention of preterm birth less than 32 weeks and 32 - 37 weeks and may be cost - effective in the other subgroups .", "label": "", "metadata": {}, "score": "74.329285"}
{"text": "Thus half of the mRS 2 - 3 patients ( \" moderate impairment \" ) were assigned NH costs and half were discharged to home with outpatient rehabilitation costs ( no incremental NH costs ) .", "label": "", "metadata": {}, "score": "74.505035"}
{"text": "J Clin Oncol 2005 , 23:8469 - 8476 .Plevritis SK , Kurian AW , Sigal BM , Daniel BL , Ikeda DM , Stockdale FE , Garber AM : Cost - effectiveness of screening BRCA1/2", "label": "", "metadata": {}, "score": "74.507324"}
{"text": "Mercer BM , Goldenberg RL , Moawad AH , Meis PJ , Iams JD , Das AF , et al .The preterm prediction study : effect of gestational age and cause of preterm birth on subsequent obstetric outcome .", "label": "", "metadata": {}, "score": "74.68648"}
{"text": "This piece of information has important implication for policy making if decision makers are concerned with achieving high probability of cost - effectiveness of the intervention in the poorest population ( Nouna villages ) and would not have been possible just by using stratified analysis on the traditional ICER approach .", "label": "", "metadata": {}, "score": "74.73038"}
{"text": "17 For neonatal death we used a utility of 0 and for a term or normal ( neonate with no complication from preterm delivery ) infant a utility score of 1 was used .", "label": "", "metadata": {}, "score": "74.819855"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : On the basis of the Survey of Health , Ageing , and Retirement ( SHARE ) , we analyse the determinants of who engages in mammography screening focusing on European women aged 50 - 69 years .", "label": "", "metadata": {}, "score": "74.895615"}
{"text": "Using a decision model that incorporates PSA the uncertainty in the decision problem , whether risedronate is cost - effective or not , could be quantified by stating the probability that the intervention will be cost - effective for a given willingness to pay level .", "label": "", "metadata": {}, "score": "74.95108"}
{"text": "Using a decision model that incorporates PSA the uncertainty in the decision problem , whether risedronate is cost - effective or not , could be quantified by stating the probability that the intervention will be cost - effective for a given willingness to pay level .", "label": "", "metadata": {}, "score": "74.95108"}
{"text": "It also avoids the problems of interpretation of a negative ICER [ 14 , 15 ] .There isa straightforward graphical representation and interpretation that a new treatment is not cost effective [ 7 ] .", "label": "", "metadata": {}, "score": "75.054115"}
{"text": "These patients were also modelled facing a monthly risk of a natural death .Hip fracture patients additionally face the risk of dying due to their fracture or may become dependent ( i.e. require home care ) or may need to move to a nursing home .", "label": "", "metadata": {}, "score": "75.177246"}
{"text": "These patients were also modelled facing a monthly risk of a natural death .Hip fracture patients additionally face the risk of dying due to their fracture or may become dependent ( i.e. require home care ) or may need to move to a nursing home .", "label": "", "metadata": {}, "score": "75.177246"}
{"text": "Results are presented in Figure 3 .Since efficacy is frequently overestimated in early clinical trials , we also explored the impact of changes in the efficacy of rFVIIa to ensure that our results would not underestimate the mCER of rFVIIa .", "label": "", "metadata": {}, "score": "75.26004"}
{"text": "10.1002/hec.4730030505 PubMed View Article .BMJ 2012 , 344 : e2292 . 10.1136/bmj.e2292 PubMed Central PubMed View Article .Ranson MK , Sinha T , Chatterjee M , Gandhi F , Jayswal R , Patel F , Morris SS , Mills AJ : Equitable utilisation of Indian community based health insurance schemes among its rural membership : cluster randomised controlled trial .", "label": "", "metadata": {}, "score": "75.281784"}
{"text": "d. Repeat steps 2 and 3 a number of times to obtain the probability distribution of the result .Typically between 100 and 1000 iterations are required depending on the number of variables and the degree of confidence required .", "label": "", "metadata": {}, "score": "75.33725"}
{"text": "Background .Economic evaluation in general , and cost - effectiveness analysis in particular is deemed by scholars , health administration and policy experts a centerpiece of the decision making process by balancing health gains against costs of interventions [ 1 ] .", "label": "", "metadata": {}, "score": "75.52537"}
{"text": "The analysis was universally sensitive to the efficacy of 17\u03b1 - hydroxyprogesterone caproate in preventing preterm delivery less than 32 weeks in all models evaluated .", "label": "", "metadata": {}, "score": "75.57529"}
{"text": "Drummond MF , Sclpher MJ , Torrance GW , O'Brien BJ , Stoddart GL : Methods for the economic evaluation of health care programmes .Oxford University Press , New - York ; 2005 .", "label": "", "metadata": {}, "score": "75.59833"}
{"text": "JAMA 2006 , 295:2374 - 2384 .Tumeh JW , Moore SG , Shapiro R , Flowers CR : Practical approach for using Medicare data to estimate costs for cost - effective- ness analysis .", "label": "", "metadata": {}, "score": "75.643166"}
{"text": "This trial did not demonstrate a clinical benefit for rFVIIa over placebo .However , a similar biologic effect was seen with regard to prevention of clot expansion .", "label": "", "metadata": {}, "score": "75.71281"}
{"text": "The purpose of this study was to determine if breast MRI is a cost - effective approach for the detection of breast cancer among young women at high risk .", "label": "", "metadata": {}, "score": "75.94627"}
{"text": "These thresholds separate the analytic space into two regions , one in which rVIIa is best ( the upper right ) and one in which usual care is best ( the lower left ) .", "label": "", "metadata": {}, "score": "76.03648"}
{"text": "To protect your most sensitive data and activities ( like changing your password ) , we 'll ask you to re - enter your password when you access these services .", "label": "", "metadata": {}, "score": "76.173805"}
{"text": "The population is essentially young with children less than 15 years of age representing about 48 % of the total population , and only 6.2 % above 60 years of age .", "label": "", "metadata": {}, "score": "76.20415"}
{"text": "Though MRI is more sensitive than mammography in a high - risk population , it has not yet been shown to reduce mortality [ 16].", "label": "", "metadata": {}, "score": "76.237"}
{"text": "Sensitivity Analyses Univariate sensitivity analyses were performed on each individual cost , probability and utility in order to explore the effect that variation in model parameters can have on the incremental cost - effectiveness of the MRI strategy .", "label": "", "metadata": {}, "score": "76.35708"}
{"text": "If they survive , they accrue additional costs for the care provided due to the ATE and also have a reduced quality of life due primarily to long - term neurological morbidity from ischemic stroke .", "label": "", "metadata": {}, "score": "76.46706"}
{"text": "It can be observed in Figure 4 that when adjusted to place ( Nouna town versus Nouna villages ) , the ceiling ratio that corresponds to a 50 % probability that the intervention is cost - effective ( ICER ) is significantly lower than the ICER computed .", "label": "", "metadata": {}, "score": "76.84906"}
{"text": "We computed ICER for extra additional utilization of health services , and cost effectiveness acceptability curves ( CEAC ) to illustrate the decision rule of cost effectiveness of the intervention .", "label": "", "metadata": {}, "score": "77.0995"}
{"text": "The primary measures of effectiveness for each strategy were 1 ) the number of preterm deliveries less than 32 weeks prevented and 2 ) the number of preterm delivery less than 37 weeks prevented and the quality - adjusted life - years gained from preventing preterm delivery .", "label": "", "metadata": {}, "score": "77.1099"}
{"text": "Background .The majority of strokes worldwide are ischemic .Ischemic stroke victims that present within three hours are eligible for thrombolytic treatment with intravenous recombinant tissue plasminogen activator ( r - tPA ) .", "label": "", "metadata": {}, "score": "77.19718"}
{"text": "The baseline efficacy of 17\u03b1 - hydroxyprogesterone caproate and probabilities for each strategy and for the outcomes were derived from a systematic review of the English literature , supplemented by bibliographic review .", "label": "", "metadata": {}, "score": "77.22374"}
{"text": "Advantages of MRS include delivery of biochemical information about tumor metabolism , which can potentially assist in the staging of cancers and monitoring responses to treatment .", "label": "", "metadata": {}, "score": "77.29682"}
{"text": "The cost - effectiveness of using MRI and mammography in combination to screen for breast cancer in BRCA1/2 mutation carriers is finely balanced .The sensitivity of the results to the cost of the MRI screen itself warrants consideration : in jurisdictions with higher MRI costs , screening may not be a cost - effective use of resources , but improving the efficiency of MRI screening will also improve cost - effectiveness .", "label": "", "metadata": {}, "score": "77.31711"}
{"text": "Furthermore , observational studies of BRCA mutation carriers suggest that 50 % of breast cancers in this population present between screening mammograms [ 4,7].", "label": "", "metadata": {}, "score": "77.342316"}
{"text": "Several studies have reported the sen- sitivity of MRI screening in high - risk women to be between 77 % and 91 % [ 14].", "label": "", "metadata": {}, "score": "77.415924"}
{"text": "Our study differs from this study in the patient cohort ; we include women at high risk as per the Claus tables whereas this study only includes women with BRCA1/BRCA2 mutations .", "label": "", "metadata": {}, "score": "77.43104"}
{"text": "Neonatal deaths were assumed to occur within the first week of delivery .For deliveries less than 32 weeks an average cost for a 28-day stay in the neonatal intensive care unit ( NICU ) was used , and for deliveries after 32 weeks an average of 2 weeks NICU stay was used .", "label": "", "metadata": {}, "score": "77.4792"}
{"text": "The study was approved by the ethical review board of Nouna Health Research Centre .Results .Descriptive analysis of the study populations .Table 2 describes the characteristics of the households included in the Nouna panel household survey by enrolment status in the Nouna CBHI scheme and by the selected covariates ( education , place , perceived quality of care , asset ownership ) .", "label": "", "metadata": {}, "score": "77.47951"}
{"text": "We rationalize how it is that different histological types of breast cancer are differentially detected and characterized by MR methods .\" For women aged 50- 69 years , mammography has been shown to lower the risk of dying from breast cancer by 35 % [ 4].", "label": "", "metadata": {}, "score": "77.50711"}
{"text": "In the early 1990s , a Demographic Surveillance System ( DSS ) was established by the Nouna Health Research Centre .The density of population was about 35 individuals per square km .", "label": "", "metadata": {}, "score": "77.56215"}
{"text": "Finally , the results of our model should be interpreted with care given that the results of this cost - effectiveness analysis require compari- sons to data from observational studies , the Surveillance , Epidemiology and End Results Program , or clinical trials .", "label": "", "metadata": {}, "score": "77.79088"}
{"text": "Post PN , Stiggelbout AM , Wakker PP : The utility of health states after stroke : a systematic review of the literature .Stroke 2001 , 32 : 1425 - 1429 .", "label": "", "metadata": {}, "score": "77.79194"}
{"text": "We hypothesized that rFVIIa would have a low marginal cost - effectiveness ratio ( mCER ) given the poor neurologic outcomes after ICH with conventional management .", "label": "", "metadata": {}, "score": "78.274994"}
{"text": "Dr. Eckman is an editorial consultant for the American College of Physicians - Physicians ' Information and Education Resource ( PIER ) module on pre - operative assessment for bleeding disorders .", "label": "", "metadata": {}, "score": "78.40457"}
{"text": "In the decision model lognormal distributions were fitted to the relative risk parameters .Parameter uncertainty in the transition probabilities was represented by beta distributions that were applied to the data by the method of moments fitting .", "label": "", "metadata": {}, "score": "78.46597"}
{"text": "In the decision model lognormal distributions were fitted to the relative risk parameters .Parameter uncertainty in the transition probabilities was represented by beta distributions that were applied to the data by the method of moments fitting .", "label": "", "metadata": {}, "score": "78.46597"}
{"text": "14 For the cost of 17\u03b1 - hydroxyprogesterone caproate in women delivering before 32 weeks , we used an average cost for a 10-week course , and an average cost for a 14-week course was used for deliveries between 32 and 37 weeks .", "label": "", "metadata": {}, "score": "78.483536"}
{"text": "These results are driven by the high success rate of minimally invasive slings compared to other treatment modalities .More studies are needed to define utility values for heath states experienced by women with stress urinary incontinence .", "label": "", "metadata": {}, "score": "78.51778"}
{"text": "These results are driven by the high success rate of minimally invasive slings compared to other treatment modalities .More studies are needed to define utility values for heath states experienced by women with stress urinary incontinence .", "label": "", "metadata": {}, "score": "78.51778"}
{"text": "Secondary outcomes include neonatal complications prevented .One - way and multiway sensitivity analyses were performed .RESULTS :The use of 17\u03b1 - hydroxyprogesterone caproate for the prevention of preterm deliveries result in cost - savings in women with prior preterm deliveries less than 32 weeks and 32 - 37 weeks .", "label": "", "metadata": {}, "score": "78.82839"}
{"text": "However , the specificity of breast MRI is variable and costs are high .The purpose of this study was to determine if breast MRI is a cost - effective approach for the detection of breast cancer among young women at high risk .", "label": "", "metadata": {}, "score": "78.83081"}
{"text": "Results .In the \" base case \" , treating ICH with rFVIIa dominates the usual care strategy by being more effective and less costly .", "label": "", "metadata": {}, "score": "78.846794"}
{"text": "Our analysis is the first to consider the economic implications of the use of 17\u03b1 - hydroxyprogesterone caproate .A previous review of the effect of the use of 17\u03b1 - hydroxyprogesterone caproate on the rate of preterm delivery suggested only a limited effect given the small group of at - risk women who are candidates for the therapy .", "label": "", "metadata": {}, "score": "78.88713"}
{"text": "There was a 14 percentage point difference ( 85.4 - 71.4 ) in the utilization of health services between members and non - members .Table 2 .", "label": "", "metadata": {}, "score": "79.06097"}
{"text": "Uni- variate sensitivity analyses are displayed in a tornado dia- gram of the most influential variables ( Figure 2 ) .In this diagram , each bar represents the impact of uncertainty in an individual variable on the ICER .", "label": "", "metadata": {}, "score": "79.18819"}
{"text": "Other models have shown that MRI screening may be cost - effective in high - risk women , particularly those with BRCA1 and BRCA2 mutations .", "label": "", "metadata": {}, "score": "79.32147"}
{"text": "Decision paths included conservative management , pelvic floor physical therapy , pelvic floor physical therapy with electrical stimulation , incontinence pessary and surgical treatment with a midurethral sling .", "label": "", "metadata": {}, "score": "79.35431"}
{"text": "Decision paths included conservative management , pelvic floor physical therapy , pelvic floor physical therapy with electrical stimulation , incontinence pessary and surgical treatment with a midurethral sling .", "label": "", "metadata": {}, "score": "79.35431"}
{"text": "View Article PubMed .Brott T , Broderick J , Kothari R , Barsan W , Tomsick T , Sauerbeck L , Spilker J , Duldner J , Khoury J : Early hemorrhage growth in patients with intracerebral hemorrhage .", "label": "", "metadata": {}, "score": "79.442665"}
{"text": "Until further studies of this type are performed , ICH remains a disease with high morbidity and mortality , with no effective medical treatment .Declarations .", "label": "", "metadata": {}, "score": "79.58806"}
{"text": "Similarly , a smaller trial using progesterone vaginal suppository reported a significant reduction of recurrence of preterm delivery in the treatment group compared with placebo .", "label": "", "metadata": {}, "score": "79.626526"}
{"text": "The probabilities included in the decision tree are shown in Table 1 . 13 The proportion of primigravid and women with prior term delivery were derived using estimates from the most recent National Vital Statistics . 1", "label": "", "metadata": {}, "score": "79.73876"}
{"text": "Decision Theory .Is a technique for assisting in reaching decisions under uncertainty and risk .All decisions are based to some extent on uncertain forecasts .", "label": "", "metadata": {}, "score": "79.79457"}
{"text": "However , based on a pre - planned interim analysis , the sample size was increased due to fewer poor outcomes than anticipated .In presenting the FAST trial results , the investigators noted that the placebo group in the FAST trial had much better 3-month outcomes than the placebo group in the Phase II trial , leading to discrepant results despite a similar biologic effect .", "label": "", "metadata": {}, "score": "79.98883"}
{"text": "Flaherty ML , Woo D , Haverbusch M , Moomaw CJ , Sekar P , Sauerbeck L , Kissela B , Kleindorfer D , Broderick JP : Potential applicability of recombinant factor VIIa for intracerebral hemorrhage .", "label": "", "metadata": {}, "score": "80.07299"}
{"text": "The aim of this study is to evaluate whether the use of 17\u03b1 - hydroxyprogesterone caproate for the prevention of recurrent preterm delivery is cost - effective .", "label": "", "metadata": {}, "score": "80.12788"}
{"text": "Obstet Gynecol 2005;105:267 - 72 .Cost analysis .In : Drummond MF , Sculpher MJ , Torrance GW , O'Brien , Stoddart GL , editors .", "label": "", "metadata": {}, "score": "80.38594"}
{"text": "Below are the links to the authors ' original submitted files for images .Competing interests .The authors declare that they have no competing interests .", "label": "", "metadata": {}, "score": "80.42511"}
{"text": "There are currently no medical therapies for ICH , and surgery to remove the blood clot is usually reserved only for severe , life - threatening ICH .", "label": "", "metadata": {}, "score": "80.5412"}
{"text": "View Article PubMed .Hardie K , Hankey GJ , Jamrozik K , Broadhurst RJ , Anderson C : Ten - year survival after first - ever stroke in the perth community stroke study .", "label": "", "metadata": {}, "score": "80.631676"}
{"text": "The funders have no responsibility for the information provided or views expressed in this paper .The views expressed herein are solely those of the authors .", "label": "", "metadata": {}, "score": "81.00129"}
{"text": "Currently , 17\u03b1 - hydroxyprogesterone caproate is produced by only few pharmaceutical companies , creating the potential for a monopolistic control of price and its long - term consequences .", "label": "", "metadata": {}, "score": "81.55428"}
{"text": "PubMed .Mayer SA , Brun NC , Broderick J , Davis S , Diringer MN , Skolnick BE , Steiner T , Europe / AustralAsia NovoSeven ICH Trial Investigators : Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage .", "label": "", "metadata": {}, "score": "81.84918"}
{"text": "Br J Cancer 2006 , 95:801 - 810 .Wainberg S , Husted J : Utilization of screening and preventive surgery among unaffected carriers of a BRCA1 or BRCA2 gene mutation .", "label": "", "metadata": {}, "score": "82.189766"}
{"text": "He is currently Maternal Health Technical Adviser at the United Nations Population Fund ( New - York ) , and served as Scientific and Technical Advisor on the WHO Alliance for Health Policy and System Research Scientific and Technical Advisory Committee .", "label": "", "metadata": {}, "score": "82.20279"}
{"text": "This table provides the results of univar- iate analyses for all model parameters . xls ] .Page 8 .Publish with BioMed Central and every scientist can read your work free of charge \" BioMed Central will be the most significant development for disseminating the results of biomedical research in our lifetime . \"", "label": "", "metadata": {}, "score": "82.32668"}
{"text": "Full - text .Because of the improved sensitivity , breast MRI is increasingly being used for detection of breast cancer among high risk young women .", "label": "", "metadata": {}, "score": "82.35646"}
{"text": "Given its thrombogenic effects , it was hypothesized that it might be useful for limiting clot expansion in patients with acute ICH .Phase I and II placebo - controlled trials of rFVIIa have been completed in acute ICH patients [ 8 , 9 ] .", "label": "", "metadata": {}, "score": "82.68831"}
{"text": "N Engl J Med 2005 , 353:1784 - 1792 .Cancer 2005 , 103:1898 - 1905 .Jama 2004 , 292:1317 - 1325 .N Engl J Med 2004 , 351:427 - 437 .", "label": "", "metadata": {}, "score": "82.69562"}
{"text": "Varying the cost and/or reducing the utility of health states following ATE did not impact results .Conclusion .Based on data from preliminary trials , treating selected ICH patients with rFVIIa results in lower cost and improved clinical outcomes .", "label": "", "metadata": {}, "score": "82.85538"}
{"text": "Pharmacoecnomics 2007 , 25 ( 10):807 - 816 .10.2165/00019053 - 200725100 - 00001 View Article .Hoch JS , Blume JD : Measuring and illustrating statistical evidence in a cost - effectiveness analysis .", "label": "", "metadata": {}, "score": "83.12834"}
{"text": "Gage BF , Cardinalli AB , Albers GW , Owens DK : Cost - effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation .", "label": "", "metadata": {}, "score": "83.18669"}
{"text": "For example , the rFVIIa treated arms ( 20 ug and 80 ug ) had a higher proportion of patients with cardiac disease ( left ventricular hypertrophy pattern on EKG ) and a higher proportion of patients with intraventricular extension of the hematoma .", "label": "", "metadata": {}, "score": "83.50224"}
{"text": "Introduction .The field of economic evaluations in health economics is undergoing a dramatic change at the moment .New methods have been developed , other methods have been refined .", "label": "", "metadata": {}, "score": "83.91016"}
{"text": "Introduction .The field of economic evaluations in health economics is undergoing a dramatic change at the moment .New methods have been developed , other methods have been refined .", "label": "", "metadata": {}, "score": "83.91016"}
{"text": "10.1186/1472 - 6963 - 6 - 68 PubMed Central PubMed View Article .Hoch JS , Dewa CS : Lessons from trial - based cost - effectiveness analysis of mental health interventions .", "label": "", "metadata": {}, "score": "84.09624"}
{"text": "For households which are not members of the scheme , there is obviously no cost incurred for membership fees .However , these households have to meet the cost of the utilization of health services out of pocket .", "label": "", "metadata": {}, "score": "84.19442"}
{"text": "da Fonseca EB , Bittar RE , Carvalho MH , Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk : a randomized placebo - controlled double - blind study .", "label": "", "metadata": {}, "score": "84.24806"}
{"text": "SH conceived the study ( as part of his doctoral thesis ) , led the data collection , constructed the database , performed the statistical analysis and drafted the manuscript .", "label": "", "metadata": {}, "score": "84.399254"}
{"text": "Lancet 2005 , 365:1687 - 1717 .van Roosmalen MS , Verhoef LCG , Stalmeier PFM , Hoogerbrugge N , van Daal WAJ : Decision Analysis of Prophylactic Surgery or Screening for BRCA1 Mutation Carriers : A More Prominent Role For Oophorectomy .", "label": "", "metadata": {}, "score": "84.40369"}
{"text": "View Article PubMed .O'Connell KA , Wood JJ , Wise RP , Lozier JN , Braun MM : Thromboembolic adverse events after use of recombinant human coagulation factor VIIa .", "label": "", "metadata": {}, "score": "84.57014"}
{"text": "Further research into the appropriate role and cost - effectiveness of screening breast MRI will better eluci- date which specific risk groups are more likely to benefit from MRI screening .", "label": "", "metadata": {}, "score": "84.57124"}
{"text": "Preterm births affect 12.5 % of pregnancies in the United States , contributing to more than 75 % of perinatal mortality and morbidity . 1 Despite many years of research and significant financial investments in efforts to prevent preterm delivery , no effective therapy has been reported , until recently .", "label": "", "metadata": {}, "score": "84.874176"}
{"text": "Messecar DC : Mammography screening for older women with and without cognitive impairment .J Gerontol Nurs 2000 , 26:14 - 24 .de Haes JCJM , de Koning HJ , van Oortmarssen GJ , van Agt HME , de Bruyn AE , van der Maas PJ : The impact of a breast cancer screening programme on quality - adjusted life - years .", "label": "", "metadata": {}, "score": "85.13008"}
{"text": "3,6 - 11,13 There has been no significant complication from 17\u03b1 - hydroxyprogesterone caproate injections ( with the exception of pain ) reported in the literature .", "label": "", "metadata": {}, "score": "85.33284"}
{"text": "Methods .We used a standard computer program ( Decision Maker ) [ 10 ] to construct and analyze decision trees and to perform sensitivity analyses .", "label": "", "metadata": {}, "score": "85.34244"}
{"text": "Am J Obstet Gynecol 1999;181:1216 - 21 .Petrini JR , Callaghan WM , Klebanoff M , Green NS , Lackritz EM , Howse JL , et al .", "label": "", "metadata": {}, "score": "85.550644"}
{"text": "Affiliated with .Abstract .Background .Phase I / II placebo - controlled clinical trials of recombinant Factor VIIa ( rFVIIa ) suggested that administration of rFVIIa within 4 hours after onset of intracerebral hemorrhage ( ICH ) is safe , limits ICH growth , and improves outcomes .", "label": "", "metadata": {}, "score": "85.57712"}
{"text": "Patients receiving treatment with rFVIIa ( upper branch of the decision node ) accrue the incremental cost of the drug .They next face the risk of arterial thromboembolism ( ATE ) , the major adverse event associated with the use of rFVIIa .", "label": "", "metadata": {}, "score": "85.73491"}
{"text": "For example , although BRCA mutation carriers may choose to undergo prophy- lactic mastectomy , many do not choose this option , with estimates ranging from 0 % to 54 % of carriers [ 11,26].", "label": "", "metadata": {}, "score": "85.807594"}
{"text": "The Claus tables is a breast cancer risk assessment tool that estimates risk based on maternal and paternal family his- tory , 1st and 2nd degree relatives , age , and family history of ovarian cancer .", "label": "", "metadata": {}, "score": "86.509094"}
{"text": "Bonneterre J , Bercez C , Bonneterre ME , Lenne X , Dervaux B : Cost- effectiveness analysis of breast cancer adjuvant treatment : FEC 50 versus FEC 100 ( FASG05 study ) .", "label": "", "metadata": {}, "score": "86.58123"}
{"text": "This Tornado diagram shows the degree to which uncertainty in individual variables affects ICER .Incremental cost and effectiveness of MRI over mammogra - phy Figure 3 Incremental cost and effectiveness of MRI over mam- mography .", "label": "", "metadata": {}, "score": "86.97422"}
{"text": "View Article PubMed .Mayer SA , Brun NC , Begtrup K , Broderick J , Davis S , Diringer MN , Skolnick BE , Steiner T , Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators : Recombinant activated factor VII for acute intracerebral hemorrhage .", "label": "", "metadata": {}, "score": "86.99453"}
{"text": "The cost per neonatal death avoided was cheapest with the use of 17\u03b1 - hydroxyprogesterone caproate for prior preterm delivery less than 32 weeks , whereas the cost per neonatal morbidity avoided favors using 17\u03b1 - hydroxyprogesterone caproate for women with prior deliveries between 32 weeks and 37 weeks .", "label": "", "metadata": {}, "score": "87.20209"}
{"text": "The use of 17\u03b1 - hydroxyprogesterone caproate was associated with cost savings in women with prior preterm delivery .The cost saved per quality - adjusted life - year gained secondary to using 17\u03b1 - hydroxyprogesterone caproate were $ 3,090 and $ 2,963 in women with prior preterm delivery less than 32 weeks and between 32 weeks and 37 weeks , respectively .", "label": "", "metadata": {}, "score": "87.22008"}
{"text": "5 After the release of the committee opinion statement , many obstetricians now prescribe 17\u03b1 - hydroxyprogesterone caproate .As with any new technology , some of the scenarios in which 17\u03b1 - hydroxyprogesterone caproate is prescribed are outside the context of the two recent trials mentioned above .", "label": "", "metadata": {}, "score": "87.40611"}
{"text": "ICH growth was 29 % in the placebo arm as compared to 14 % in the 80 mcg / kg group ; mortality at 90 days was reduced from 29 % in the placebo arm to 18 % in the 80 mcg / kg rFVIIa arm .", "label": "", "metadata": {}, "score": "87.41245"}
{"text": "Cost - effectiveness acceptability curves , Nouna CBHI , Burkina Faso .The interventions .The intervention has been extensively described in the literature [ 9 - 13 ] .", "label": "", "metadata": {}, "score": "87.969475"}
{"text": "The natural history for women with a prior preterm delivery and their performance in subsequent pregnancies were derived from the results of the Maternal Fetal Medicine Units network study 13 and from the report by Petrini et al 14 using data from the States of Missouri and New Jersey .", "label": "", "metadata": {}, "score": "87.989876"}
{"text": "Am J Obstet Gynecol 2005;193:1127 - 31 .What does \" Remember me \" mean ?By checking this box , you 'll stay logged in until you logout .", "label": "", "metadata": {}, "score": "88.58457"}
{"text": "In our model , a mRS of 4 - 5 mapped to an ICH with \" severe \" neurological sequelae , while mRS of 2 - 3 and 0 - 1 mapped to \" moderate \" and \" mild \" sequelae , respectively .", "label": "", "metadata": {}, "score": "88.79068"}
{"text": "PubMed .Stroke 2004 , 35 : 426 - 431 .View Article PubMed .Flaherty ML , Haverbusch M , Sekar P , Kissela B , Kleindorfer D , Moomaw CJ , Sauerbeck L , Schneider A , Broderick JP , Woo D : Long - term mortality after intracerebral hemorrhage .", "label": "", "metadata": {}, "score": "88.84834"}
{"text": "\u00a9 Hounton and Newlands ; licensee BioMed Central Ltd. 2012 .This article is published under license to BioMed Central Ltd.Expected Value of Perfect Information ' calculations in health economics .", "label": "", "metadata": {}, "score": "88.94672"}
{"text": "All computations were performed using a commercially available decision - analysis software package ( TreeAge Pro 2005 , Tree Age Inc , Williamstown , MA ) and STATA 8.0 ( StataCorp LP , College Station , TX ) .", "label": "", "metadata": {}, "score": "89.1627"}
{"text": "The latter report however , did not consider the cost implications of the use of 17\u03b1 - hydroxyprogesterone caproate .Given the inexpensive and safe nature of 17\u03b1 - hydroxyprogesterone caproate , further studies evaluating new subgroups of women who could benefit from 17\u03b1 - hydroxyprogesterone caproate are needed .", "label": "", "metadata": {}, "score": "89.238846"}
{"text": "a. Primary is the sense of personal control and the ability to mange the risk .b. Secondary are qualities of familiarity and conversely , dread .", "label": "", "metadata": {}, "score": "90.000824"}
{"text": "No criticism or disapproving verbal or nonverbal behaviors are allowed .The intent is to encourage as many ideas as possible , which may in turn , trigger the ideas of others .", "label": "", "metadata": {}, "score": "90.72142"}
{"text": "Both authors read and approved the final manuscript .Authors ' Affiliations .Department of Neurology , University of Cincinnati .Division of General Internal Medicine and the Center for Clinical Effectiveness , University of Cincinnati .", "label": "", "metadata": {}, "score": "91.82599"}
{"text": "Le - Petross HT : Breast MRI as a screening tool : the appropriate role .J Natl Compr Canc Netw 2006 , 4:523 - 526 .", "label": "", "metadata": {}, "score": "92.15327"}
{"text": "Other terms may apply .", "label": "", "metadata": {}, "score": "92.2626"}
{"text": "Although the current indication for 17\u03b1 - hydroxyprogesterone caproate is in women with prior preterm delivery , we sought to determine whether the medication may be cost - effective in other patient populations , such as those with no prior delivery or with previous term delivery .", "label": "", "metadata": {}, "score": "92.35649"}
{"text": "10.1007/s10198 - 006 - 0031 - 4 PubMed View Article .Dong H , Kouyate B , Cairns J , Mugisha F , Sauerborn R : Willingness - to - pay for community - based insurance in Burkina Faso .", "label": "", "metadata": {}, "score": "92.62628"}
{"text": "Decision Model Structure and Assumptions .Model Structure and Parameters .We used the modified Rankin Scale ( mRS ) to describe neurological outcomes as in the Phase II trial .", "label": "", "metadata": {}, "score": "92.986824"}
{"text": "All authors read and approved the final manuscript .Authors ' Affiliations .Department of Epidemiology , Centre MURAZ .Business School , University of Aberdeen .", "label": "", "metadata": {}, "score": "93.80832"}
{"text": "ative with BRCA1/BRCA2/TP53 mutation or had strong family history of breast / ovarian cancer .Also this study dif- fers from our model in that , this study evaluated the cost effectiveness of MRI alone , mammography alone , and mammography in combination with MRI .", "label": "", "metadata": {}, "score": "94.2629"}
{"text": "BACKGROUND : .In Japan , gargling is a generally accepted way of preventing upper respiratory tract infection ( URTI ) .The effectiveness of gargling for preventing URTI has been shown in a randomized controlled trial that compared incidences of URTI between gargling and control groups .", "label": "", "metadata": {}, "score": "94.428986"}
{"text": "View Article PubMed .A Report From the American Heart Association Statistics Committee and Stroke Statistics Committee .Circulation 2006 , 113 ( 6 ) : e85 - 151 .", "label": "", "metadata": {}, "score": "94.864136"}
{"text": "Simple net - benefit regression estimates with different ceiling ratios , and covariates adjusted net - benefit regression estimates , Nouna community based health insurance , household survey , 2007 , Burkina Faso .", "label": "", "metadata": {}, "score": "94.86485"}
{"text": "Authors ' information .Sennen Hounton is a medical epidemiologist with expertise in maternal and newborn health , health systems and economic evaluation .Sennen Hounton is has an MD ( Benin ) , MPH in Epidemiology ( University of Oklahoma , USA ) and a PhD in Public Health from University of Aberdeen , ( Scotland , UK ) .", "label": "", "metadata": {}, "score": "95.08046"}
{"text": "Monte Carlo .The Monte Carlo method , simulation by means of random numbers , provides a powerful yet simple method of incorporating probabilistic data .", "label": "", "metadata": {}, "score": "95.8383"}
{"text": "We next explored the impact of changes in the efficacy of rFVIIa in preventing major neurological sequelae ( i. e. , mRS 4 - 5 ) and in the efficacy of rFVIIa in preventing death .", "label": "", "metadata": {}, "score": "96.01128"}
{"text": "PubMed View Article .Dong H , Gbangou A , De Allegri M , Pokhrel S , Sauerborn R : The differences in characteristics between health - care users and non - users : implication for introducing community - based health insurance in Burkina Faso .", "label": "", "metadata": {}, "score": "96.2263"}
{"text": "Table 4 .Simple net - benefit regression estimates with different ceiling ratios , Nouna community based health insurance , household survey , 2007 , Burkina Faso .", "label": "", "metadata": {}, "score": "96.329834"}
{"text": "Bevers TB , Anderson BO , Bonaccio E , Borgen PI , Buys S , Daly MB , Dempsey PJ , Farrar WB , Fleming I , Garber JE , et al .", "label": "", "metadata": {}, "score": "96.610985"}
{"text": "D\u00fcsseldorf , K\u00f6ln : German Medical Science ; 2006 .Doc06gmds033 .\u00a9 2006 Bischof .Er darf vervielf\u00e4ltigt , verbreitet und \u00f6ffentlich zug\u00e4nglich gemacht werden , vorausgesetzt dass Autor und Quelle genannt werden .", "label": "", "metadata": {}, "score": "96.89929"}
{"text": "JEL Classification C 36 , I 11 , I 18 Wolters Kluwer Health may email you for journal alerts and information , but is committed to maintaining your privacy and will not share your personal information without your express consent .", "label": "", "metadata": {}, "score": "96.92839"}
{"text": "17\u03b1 - hydroxyprogesterone Caproate for the Prevention of Preterm Delivery : A Cost - effectiveness Analysis .Author Information .From the Departments of Obstetrics and Gynecology and Center for Clinical Epidemiology and Biostatistics , Internal Medicine and Health Management Systems , 1 Washington University Medical Center in St. Louis , Missouri ; 2 University of Pennsylvania ; and 3 Leonard Davis Institute , Philadelphia , Pennsylvania .", "label": "", "metadata": {}, "score": "97.3609"}
{"text": "This information could be useful in developing policies regarding the use of 17\u03b1 - hydroxyprogesterone caproate in pregnancy .MATERIALS AND METHODS .Decision - analysis models evaluating four distinct subgroups considered for the use of 17\u03b1 - hydroxyprogesterone caproate for the prevention of preterm births were created .", "label": "", "metadata": {}, "score": "97.79253"}
{"text": "Dong H , De Allegri M , Gnawali D , Souares A , Sauerborn R : Drop - out analysis of community - based health insurance membership at Nouna , Burkina Faso .", "label": "", "metadata": {}, "score": "98.27583"}
{"text": "He is currently a Senior Lecturer at the Business School of University of Aberdeen , Scotland , UK .Declarations .Acknowledgements .This work was undertaken as part of Dr Sennen Hounton 's doctoral programme , funded by the international research programme - Immpact , University of Aberdeen .", "label": "", "metadata": {}, "score": "98.30903"}
{"text": "NOTE :The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern ( Intel ) Mac , there is no official plugin for viewing PDF files within the browser window .", "label": "", "metadata": {}, "score": "98.518875"}
{"text": "Authors ' contributions SGM and CRF conceived the study , designed the research , and performed the statistical analysis .JWT and PJS designed the research , performed the statistical analysis , and drafted the manuscript .", "label": "", "metadata": {}, "score": "98.52515"}
{"text": "PubMed .Pre - publication history .Copyright .\u00a9 Kissela and Eckman .This article is published under license to BioMed Central Ltd.Breast magnetic resonance imaging ( MRI ) is a sensitive method of breast imaging virtually uninfluenced by breast density .", "label": "", "metadata": {}, "score": "99.5055"}
{"text": "Magnetic resonance imaging and spectroscopy ( MRI / MRS ) has gained in importance in the last decade for the diagnosis and monitoring of breast cancer therapy .", "label": "", "metadata": {}, "score": "100.20967"}
{"text": "Stroke 2004 , 35 : e27 - 9 .View Article PubMed .Stroke 2005 , 36 : 1232 - 1240 .View Article PubMed .", "label": "", "metadata": {}, "score": "100.38652"}
{"text": "Quadrant III represents a situation where MRI screening is both less costly and less effective while Quadrant IV rep- resents a situation where the MRI screening strategy is less costly and more effective ( superior ) .", "label": "", "metadata": {}, "score": "101.1296"}
{"text": "Cost - effectiveness of gargling for the prevention of upper respiratory tract infections . 1 Department of Clinical Research and Informatics , Research Institute , International Medical Center of Japan , Tokyo , Japan .", "label": "", "metadata": {}, "score": "101.66241"}
{"text": "National Comprehensive Cancer Network : Practice Guidelines in Oncology - Genetic / Familial High - Risk Assessment : Breast and Ovarian .Volume 1 .National Comprehensive Cancer Network , Inc ; 2005 .", "label": "", "metadata": {}, "score": "102.10324"}
{"text": "Cost - effectiveness acceptability curves from the net - benefit regression , Nouna CBHI , household survey , 2007 , Burkina Faso .Unadjusted cost - effectiveness acceptability curves , Nouna CBHI overall and with covariate place , Burkina Faso .", "label": "", "metadata": {}, "score": "103.12005"}
{"text": "New York ( NY ) : Oxford University Press ; 2005 .p. 77 .Spong CY , Meis PJ , Thom EA , Sibai B , Dombrowski MP , Moawad AH , et al .", "label": "", "metadata": {}, "score": "103.91347"}
{"text": "Arias E : United States life tables , 2002 .In National vital statistics reports Volume 53 .Hyattsville , Maryland : National Center for Health Statistics ; 2004 .", "label": "", "metadata": {}, "score": "105.19197"}
{"text": "Deutsche Gesellschaft f\u00fcr Medizinische Informatik , Biometrie und Epidemiologie e . V. ( gmds ) .Jahrestagung der Deutschen Gesellschaft f\u00fcr Medizinische Informatik , Biometrie und Epidemiologie .", "label": "", "metadata": {}, "score": "105.33135"}
{"text": "We made the assumption that 50 % of these ATE events were ischemic strokes ( IS ) and 50 % were myocardial infarctions ( MI ) based on data from a recent review of complications with rFVIIa use [ 12 ] .", "label": "", "metadata": {}, "score": "105.61063"}
{"text": "Suche in Medline nach .Deutsche Gesellschaft f\u00fcr Medizinische Informatik , Biometrie und Epidemiologie e . V. ( gmds ) .Jahrestagung der Deutschen Gesellschaft f\u00fcr Medizinische Informatik , Biometrie und Epidemiologie .", "label": "", "metadata": {}, "score": "106.431366"}
{"text": "The authors would like to acknowledge Margaret Baker for manuscript preparation .Competing interests .The authors declare that they have no competing interests .Non - financial competing interests .", "label": "", "metadata": {}, "score": "107.1366"}
{"text": "If you 're using a public computer or you share this computer with others , we recommend that you uncheck the \" Remember me \" box .", "label": "", "metadata": {}, "score": "107.26074"}
{"text": "AE PubMed Central PubMed View Article .Lancet 2006 , 367 ( 9507):327 - 332 .10.1016/S0140 - 6736(06)68070 - 7 PubMed View Article .", "label": "", "metadata": {}, "score": "107.75"}
{"text": "Files in this item .This item is available under the Attribution - NonCommercial - NoDerivs 3.0 Ireland .No item may be reproduced for commercial purposes .", "label": "", "metadata": {}, "score": "109.22374"}
{"text": "General practice .en . dc.subject .Cost - effectiveness analysis .en . dc.subject .Irish Centre for Social Gerontology . en .dc.title .", "label": "", "metadata": {}, "score": "109.60391"}
{"text": "Table 3 .Sample statistics from the economic evaluation of the Nouna CBHI , data with net - benefit , household survey , 2007 , Nouna districts Burkina Faso .", "label": "", "metadata": {}, "score": "110.13127"}
{"text": "Context and participants .The Nouna health district , also referred to as Kossi province , is a rural health district situated in the North West of Burkina Faso .", "label": "", "metadata": {}, "score": "112.08364"}
{"text": "D\u00fcsseldorf , K\u00f6ln : German Medical Science ; 2006 .Doc06gmds033 .\u00a9 2006 Bischof .You are free : to Share - to copy , distribute and transmit the work , provided the original author and source are credited .", "label": "", "metadata": {}, "score": "119.993164"}
{"text": "dc.identifier.uri . en .dc.description.abstract .Objectives : The Secondary Prevention of Heart disEase in geneRal practicE( SPHERE ) trial has recently reported .This study examines the cost - effectiveness of the SPHERE intervention in both healthcare systems on the island of Ireland .", "label": "", "metadata": {}, "score": "128.75327"}
